Corcept Therapeutics Inc. (NASDAQ: CORT) is one of the 10 best biotech stocks with highest upside potential.
Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics Market Following Major U.S. Regulatory ...
Young biotechs usually get acquired instead of profitably selling their own medicines. A growing number are proving they can, ...
On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended ...
Hemab Therapeutics Holdings Inc., a clinical-stage biotechnology company, is seeking to raise as much as $212 million in a US ...
Angel investors are raising the bar with tighter criteria, backing strong teams, realistic markets and clear paths to exit ...
Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the first quarter ended March 31, 2026. First ...
State Street SPDR S&P Biotech ETF (XBI) gained +40.32% over the past year and equally weights roughly 145 stocks to provide exposure to smaller biotech companies. iShares Biotechnology ETF (IBB) ...
Hosted on MSN
UK biotech financing jumps 18% as firms eye R&D push
UK biotech companies raised £552 million in equity financing in Q1 2026, marking an 18% increase from the prior quarter, with venture capital up 17%. The capital was distributed among more firms than ...
Biopharma is rebounding across rare disease, oncology and neuroscience. Here, Cytokinetics achieved a rare milestone: a first ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. In 2025, biotechnology stocks had their best year since the COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results